Human medicines European public assessment report (EPAR): Joenja, leniolisib, Status: Opinion
Orphan designation: tarlatamab Treatment of small cell lung cancer, 12/01/2024 Positive
Orphan designation: lurbinectedin Treatment of small cell lung cancer, 26/02/2019 Positive
Orphan designation: Leniolisib Treatment of activated phosphoinositide 3-kinase delta syndrome, 19/10/2020 Positive
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2026
EMA recommends restricting use of Tecovirimat SIGA
Summary of opinion: Hympavzi, 26/03/2026 Positive
Summary of opinion: Namuscla, 26/03/2026 Positive
Summary of opinion: Sotyktu, 26/03/2026 Positive
Summary of opinion: Lojuxta, 26/03/2026 Positive